et_marketsabout 3 hours ago
BULLISH(90%)
sell
Published on the original source: 1 Apr 2026, 10:01 AM IST
War-proof stocks: Why 45 names soared even as Iran-US conflict caused mayhem in Indian stock market
Read original sourceAI Analysis
The pharma sector is showing resilience, driven by domestic demand and potentially benefiting from a 'war-proof' investment thesis. Recent budget announcements (Biopharma Shakti Plan) and positive analyst outlooks further support this trend.
Trading Insight
Maintain a bullish bias on select pharma stocks, focusing on companies with strong domestic presence and stable product pipelines, with a stop-loss below recent support levels.
Quick check: SUNPHARMA bearish bias (-1.8% 1d), CIPLA bearish bias (oversold).
Key Evidence
- •Indian stocks are defying global market fears.
- •Pharma, energy, and industrial companies are delivering positive returns.
- •Investors are favoring domestic power producers and renewable energy players.
- •Commodity-linked stocks are also gaining traction.
- •This trend highlights a shift towards defensive and domestically focused investments in uncertain times.
AI-powered analysis by
Anadi Algo News